Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
12923 | 1 | BIOSIMILAR//CT P13//ANTI ERYTHROPOIETIN ANTIBODIES | 903 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BIOSIMILAR | authKW | 6063824 | 35% | 55% | 318 |
2 | CT P13 | authKW | 1159777 | 4% | 92% | 36 |
3 | ANTI ERYTHROPOIETIN ANTIBODIES | authKW | 769271 | 3% | 96% | 23 |
4 | FOLLOW ON BIOLOGICS | authKW | 628203 | 3% | 75% | 24 |
5 | SIMILAR BIOTHERAPEUTIC PRODUCTS | authKW | 418810 | 1% | 100% | 12 |
6 | PURE RED CELL APLASIA | authKW | 378636 | 6% | 19% | 58 |
7 | BIOSIMILARITY | authKW | 331539 | 2% | 50% | 19 |
8 | SUBSEQUENT ENTRY BIOLOGICS | authKW | 244306 | 1% | 100% | 7 |
9 | INTERCHANGEABILITY | authKW | 239521 | 3% | 22% | 31 |
10 | REFERENCE PRODUCT | authKW | 213766 | 1% | 88% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3427 | 37% | 0% | 331 |
2 | Rheumatology | 1275 | 7% | 0% | 64 |
3 | Urology & Nephrology | 1050 | 11% | 0% | 95 |
4 | Biotechnology & Applied Microbiology | 505 | 11% | 0% | 102 |
5 | Transplantation | 311 | 4% | 0% | 38 |
6 | Gastroenterology & Hepatology | 296 | 6% | 0% | 55 |
7 | Medicine, Research & Experimental | 282 | 8% | 0% | 70 |
8 | Immunology | 265 | 10% | 0% | 89 |
9 | Oncology | 236 | 10% | 0% | 94 |
10 | Biochemical Research Methods | 210 | 6% | 0% | 54 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOSIMILARS DEV | 139603 | 0% | 100% | 4 |
2 | IMED MED | 139603 | 0% | 100% | 4 |
3 | GLOBAL BIOPHARMACEUT DEV | 104703 | 0% | 100% | 3 |
4 | GLOBAL ESTABLISHED PHARMA MED DEV GRP | 104703 | 0% | 100% | 3 |
5 | SANDOZ BIOPHARMACEUT | 89335 | 1% | 32% | 8 |
6 | SCML | 78525 | 0% | 75% | 3 |
7 | CLIN PLANNING MED AFFAIRS | 69802 | 0% | 100% | 2 |
8 | DEV STRATEGIES GRP | 69802 | 0% | 100% | 2 |
9 | FDA REGULATORY STRATEGY POLICY | 69802 | 0% | 100% | 2 |
10 | OFF BIOL 1 | 69802 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIODRUGS | 59924 | 5% | 4% | 42 |
2 | BIOLOGICALS | 31941 | 4% | 3% | 36 |
3 | MABS | 8588 | 2% | 2% | 14 |
4 | EJHP PRACTICE | 8580 | 1% | 4% | 7 |
5 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 8083 | 2% | 2% | 15 |
6 | BIOPHARM INTERNATIONAL | 6269 | 1% | 2% | 10 |
7 | JOURNAL OF CROHNS & COLITIS | 4440 | 1% | 1% | 12 |
8 | EXPERT OPINION ON BIOLOGICAL THERAPY | 4054 | 2% | 1% | 16 |
9 | JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY | 3854 | 1% | 2% | 6 |
10 | BIOTECHNOLOGY LAW REPORT | 3690 | 0% | 3% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |